Abera Bioscience AB (NGM:ABERA)
Sweden
· Delayed Price · Currency is SEK 7.30
-0.85 (-10.43%)
At close: May 13, 2025
Abera Bioscience AB Market Cap
Abera Bioscience AB has a market cap or net worth of 121.28 million as of May 14, 2025. Its market cap has increased by 67.04% in one year.
Market Cap
121.28M
Enterprise Value
115.78M
Revenue
16.15M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.30
Market Cap Chart
Since February 24, 2021, Abera Bioscience AB's market cap has increased from 115.59M to 121.28M, an increase of 4.93%. That is a compound annual growth rate of 1.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 112.07M | 61.86% |
| Dec 30, 2024 | 69.24M | -7.23% |
| Dec 29, 2023 | 74.63M | 20.46% |
| Dec 30, 2022 | 61.96M | -64.21% |
| Dec 30, 2021 | 173.12M | 49.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Investor AB | 901.85B |
| Atlas Copco AB | 758.22B |
| AB Volvo | 561.09B |
| EQT AB | 349.24B |
| ASSA ABLOY AB | 343.67B |
| Skandinaviska Enskilda Banken AB | 327.63B |
| Swedbank AB | 281.35B |
| Telefonaktiebolaget LM Ericsson | 275.81B |